MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-19-2025
Country |
 USA |
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
4.66 M |
Market Cap[1] |
$ 1.54 M |
EBITDA (LTM) |
$ -10.5 M |
P/E (LTM) |
- |
P/S (LTM) |
0.32 |
EPS (LTM) |
1.68 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Brainsway Ltd.
BWAY
|
$ 19.0 | -1.91 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
$ 20.35 | -3.9 % | $ 219 M | Nasdaq Global Market |  China |
 |
Co-Diagnostics
CODX
|
$ 0.23 | -3.36 % | $ 6.75 M | Nasdaq Capital Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 39.13 | -0.69 % | $ 1.09 B | Nasdaq Global Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 231.04 | 0.3 % | $ 169 B | NYSE,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 10.36 | 3.19 % | $ 294 M | Nasdaq Capital Market | Israel |
 |
BioNano Genomics
BNGO
|
$ 1.51 | -0.99 % | $ 1.92 M | Nasdaq Capital Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 101.8 | 0.23 % | $ 18.9 B | Nasdaq Capital Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
DexCom
DXCM
|
$ 67.74 | 0.24 % | $ 26.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Fulgent Genetics
FLGT
|
$ 26.57 | -0.56 % | $ 803 M | Nasdaq Global Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 19.14 | -1.77 % | $ 1.03 B | Nasdaq Global Market,SPB | USA |
 |
Celcuity
CELC
|
$ 100.96 | -1.26 % | $ 3.98 B | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.19 | -0.31 % | $ 102 K | Nasdaq Capital Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
IQVIA Holdings
IQV
|
$ 227.39 | 0.21 % | $ 41.2 B | NYSE,SPB | USA |
 |
Guardant Health
GH
|
$ 101.27 | -1.67 % | $ 12.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 7.19 | 0.84 % | $ 1.56 B | Nasdaq Global Select Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 6.36 | -1.93 % | $ 576 M | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 19.02 | 1.93 % | $ 467 M | Nasdaq Global Select Market | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.67 | -8.07 % | $ 2.51 M | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 27.25 | 0.53 % | $ 20 B | NYSE |  Niderland |
 |
Personalis
PSNL
|
$ 8.03 | -1.35 % | $ 476 M | Nasdaq Global Select Market | USA |
 |
Illumina
ILMN
|
$ 134.32 | -0.47 % | $ 21.4 B | Nasdaq Global Select Market,SPB | USA |
 |
RadNet
RDNT
|
$ 72.95 | -0.27 % | $ 5.33 B | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 202.73 | -0.41 % | $ 10.4 B | NYSE,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
$ 47.5 | -0.31 % | $ 1.91 B | Nasdaq Capital Market | USA |
 |
Quidel Corporation
QDEL
|
$ 29.16 | -0.48 % | $ 1.23 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 175.35 | -0.34 % | $ 19.5 B | NYSE,SPB | USA |
|
Biodesix
BDSX
|
$ 6.79 | -0.44 % | $ 880 M | Nasdaq Global Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
$ 252.96 | -0.37 % | $ 21.2 B | NYSE,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 182.54 | -0.16 % | $ 15.1 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 684.86 | -0.53 % | $ 56.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 66.89 | 0.27 % | $ 4.63 B | Nasdaq Global Select Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 417.22 | -0.2 % | $ 30.1 B | NYSE,SPB |  Schweiz |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.